BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34560139)

  • 1. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination.
    Zavala-Miranda MF; González-Ibarra SG; Pérez-Arias AA; Uribe-Uribe NO; Mejia-Vilet JM
    Kidney Int; 2021 Dec; 100(6):1340-1341. PubMed ID: 34560139
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine.
    Tuschen K; Bräsen JH; Schmitz J; Vischedyk M; Weidemann A
    Kidney Int; 2021 Oct; 100(4):941-944. PubMed ID: 34352310
    [No Abstract]   [Full Text] [Related]  

  • 3. New-onset class III lupus nephritis with multi-organ involvement after COVID-19 vaccination.
    Kim HJ; Jung M; Lim BJ; Han SH
    Kidney Int; 2022 Apr; 101(4):826-828. PubMed ID: 35108572
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic lupus erythematosus after COVID-19 vaccination: A case report.
    Patil S; Patil A
    J Cosmet Dermatol; 2021 Oct; 20(10):3103-3104. PubMed ID: 34418261
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the editor regarding the article ''Patil S, Patil A. Systemic lupus erythematosus after COVID-19 vaccination: A case report. J Cosmet Dermatol. 2021 Aug 21. 10.1111/jocd.14386".
    Abdullah L; Awada B; Kurban M; Abbas O
    J Cosmet Dermatol; 2021 Dec; 20(12):4076-4077. PubMed ID: 34699662
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
    Barbhaiya M; Levine JM; Siegel CH; Bykerk VP; Jannat-Khah D; Mandl LA
    Clin Rheumatol; 2022 May; 41(5):1619-1622. PubMed ID: 34716843
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relapse of lupus nephritis in temporal association with anti SARS-CoV-2 vaccination].
    Muñoz LM; Bertoli AM; Rigo D; Sanchez Freytes M
    Medicina (B Aires); 2022; 82(6):971-973. PubMed ID: 36571541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo lupus nephritis after SARS-CoV-2 infection.
    Mok CC; Chu CS; Tse SM
    Lupus; 2023 Jun; 32(7):893-899. PubMed ID: 37173871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ocular adverse event in temporal association with COVID-19 vaccination in a patient with systemic lupus erythematosus: a case report.
    Jin W; Tang Y; Wen C
    Hum Vaccin Immunother; 2021 Nov; 17(11):4102-4104. PubMed ID: 34617875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.
    Kreuter A; Burmann SN; Burkert B; Oellig F; Michalowitz AL
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e733-e735. PubMed ID: 34243220
    [No Abstract]   [Full Text] [Related]  

  • 11. ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 vaccination: a case report and literature review.
    Campos MAG; Valois TO; Magalhães LE; Vasques LF; de Medeiros RG; Costa DMDN; Salgado Filho N; Nogueira RMDR; Neves PDMM; Silva GEB
    Front Immunol; 2023; 14():1298622. PubMed ID: 38299140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
    Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.
    Ceccarelli F; Olivieri G; Natalucci F; Alessandri C; Conti F
    Lupus; 2021 Sep; 30(10):1698-1699. PubMed ID: 34192958
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of vaccination of patients with systemic lupus erythematosus.
    Abu-Shakra M
    Lupus; 2009 Nov; 18(13):1205-8. PubMed ID: 19880569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emergence of new-onset SLE following SARS-CoV-2 vaccination.
    Nune A; Iyengar KP; Ish P; Varupula B; Musat CA; Sapkota HR
    QJM; 2021 Dec; 114(10):739-740. PubMed ID: 34450645
    [No Abstract]   [Full Text] [Related]  

  • 16. Lupus, vaccinations and COVID-19: What we know now.
    Mason A; Anver H; Lwin M; Holroyd C; Faust SN; Edwards CJ
    Lupus; 2021 Sep; 30(10):1541-1552. PubMed ID: 34134555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Lupus Erythematosus and COVID-19.
    Pappa M; Panagiotopoulos A; Thomas K; Fanouriakis A
    Curr Rheumatol Rep; 2023 Oct; 25(10):192-203. PubMed ID: 37477841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-onset lupus nephritis associated with COVID-19 infection.
    Kazzi B; Fine D; Geetha D; Chung M; Monroy-Trujillo M; Timlin H
    Lupus; 2022 Jul; 31(8):1007-1011. PubMed ID: 35485455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine.
    Joseph AK; Chong BF
    Dermatol Ther; 2021 Nov; 34(6):e15114. PubMed ID: 34455671
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 and SLE: Infection and autoimmunity at its best.
    Mahroum N; Elsalti A; Ozkan MF; Shoenfeld Y
    Lupus; 2023 Dec; 32(14):1591-1597. PubMed ID: 37927085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.